You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Netrin-1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Placenta Accreta Trial in Assiut (Pregnant women at 28-32 weeks, at delivery)

Completed
  • Placenta Accreta
  • Pregnant women at 28-32 weeks
  • at delivery
  • Assiut, Egypt
    Woman's Health Hospital
Aug 19, 2022

Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Lyon, France
    Centre Léon Bérard
Nov 30, 2023

Inflammatory Response, Obesity Trial in Guadalajara (Thymol)

Recruiting
  • Inflammatory Response
  • Obesity
  • Guadalajara, Jalisco, Mexico
    INTEC, CUCS, Universidad de Guadalajara
Jun 17, 2022

Advanced Solid Tumor, Endometrial Carcinoma, Hormone Receptor Positive Trial in Lyon, Nantes, Toulouse (NP137 DL and RP2D)

Completed
  • Advanced Solid Tumor
  • +2 more
  • NP137 DL and RP2D
  • Lyon, France
  • +2 more
Jul 22, 2022

Advanced Solid Tumors, Metastatic Solid Tumors Trial in Lyon (NP137, anti-PD-1/PD-L1)

Recruiting
  • Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Lyon, France
    Centre Léon Bérard
Nov 30, 2022

Netrin-1 & Hepatocellular Carcinoma HCC

Recruiting
  • HCC
  • Quantification of netrin-1 signals by antibody-based approaches
  • Lyon, France
    Hepatogastroenterology service of the Croix-Rousse Hospital
Feb 19, 2021

Endometrial Carcinoma, Cervix Carcinoma Trial in France (NP137, Pembrolizumab, Paclitaxel)

Recruiting
  • Endometrial Carcinoma
  • Cervix Carcinoma
  • Bordeaux, France
  • +11 more
Jun 7, 2022

Netrin-1 in the Pathophysiology of Placenta Accreta Spectrum

Unknown status
  • Pathophysiology of Placenta Accreta
    • (no location specified)
    Nov 9, 2020

    Anti-inflammatory Markers in Endometrioma

    Completed
    • Endometrioma
    • Inflammation
    • Adropin (ng/L)
    • Muğla, Turkey
      Mugla Sıtkı Kocman University Faculty of Medicine
    Apr 30, 2020

    Acute Coronary Syndrome Trial (netrin-1 value on admission to hospital)

    Completed
    • Acute Coronary Syndrome
    • netrin-1 value on admission to hospital
    • (no location specified)
    Jul 18, 2019

    Periodontitis Trial in Bolu (non surgical periodontal treatment, Gingival crevicular fluid, saliva and serum collection)

    Completed
    • Periodontitis
    • non surgical periodontal treatment
    • Gingival crevicular fluid, saliva and serum collection
    • Bolu, Turkey
      Bolu Abant Izzet Baysal University
    Apr 17, 2019

    N/LP Ratio as Predictor of Mortality in Septic AKI Patients

    Not yet recruiting
    • Acute Kidney Injury Due to Sepsis
      • (no location specified)
      Oct 1, 2022

      Early Recognition of Acute Kidney Injury After Orthopedic

      Recruiting
      • Hip Fractures
      • Acute Kidney Injury
      • Biomarker
      • RRI measurement
      • Otwock, Mazowieckie, Poland
      • +1 more
      Apr 4, 2022

      Desflurane Versus Sevoflurane With Recent Bio-markers on Renal

      Completed
      • Postoperative Complications
      • Neutrophil Gelatinase-Associated Lipocalin (NGAL)
      • +2 more
      • Cairo, Egypt
        Theodor Bilharz Research Institute
      Aug 23, 2021

      Kidney Stones Trial in Konya (Endoscopic kidney stone surgery, Non-invasive kidney stone treatment)

      Suspended
      • Kidney Stones
      • Endoscopic kidney stone surgery
      • Non-invasive kidney stone treatment
      • Konya, Turkey
        Selcuk University, School of Medicine, Department of Urology
      Nov 15, 2019

      Postoperative Pain, Postoperative Cognitive Dysfunction Trial in Tianjin (Normal saline, S-ketamine (low-dose), S-ketamine

      Recruiting
      • Postoperative Pain
      • Postoperative Cognitive Dysfunction
      • Normal saline
      • +2 more
      • Tianjin, China
        Tianjin Medical University General Hospital
      Aug 7, 2021

      Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

      Completed
      • Rheumatoid Arthritis
      • LNK01001 Dose A
      • +2 more
      • Beijing, China
        Peking Union Medical College Hospital
      Oct 24, 2023

      COVID-19 Trial in Thái Bình (COVIVAC vaccine)

      Completed
      • COVID-19
      • COVIVAC vaccine
      • Thái Bình, Thai Binh, Vietnam
        District Health Center of Vu Thu District
      Jul 12, 2023

      Ankylosing Spondylitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, Placebo)

      Completed
      • Ankylosing Spondylitis
      • LNK01001 Dose A
      • +2 more
      • Beijing, China
        Peking Union Medical College Hospital
      Oct 10, 2023

      Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)

      Not yet recruiting
      • Relapsing Remitting Multiple Sclerosis
      • PIPE-307 Dose A
      • +2 more
      • (no location specified)
      Oct 9, 2023

      Meningococcal Meningitis Trial in Surabaya (batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of

      Not yet recruiting
      • Meningococcal Meningitis
      • batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
      • +3 more
      • Surabaya, Indonesia
        Husada Utama Hospital
      Nov 13, 2023

      Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • iNKT Cells
      • +2 more
      • Beijing, Beijing, China
        Beijing Youan Hospital,Capital Medical University
      Jul 24, 2023

      Atopic Dermatitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

      Completed
      • Atopic Dermatitis
      • LNK01001 Dose A
      • +2 more
      • Beijing, China
        Jianzhong Zhang
      Oct 10, 2023

      Hypertension,Essential Trial in China (Songling Xuemaikang Capsules, Lifestyle intervention, Placebo)

      Not yet recruiting
      • Hypertension,Essential
      • Songling Xuemaikang Capsules
      • +2 more
      • Beijing, Beijing, China
      • +4 more
      Oct 17, 2023

      Diabetes Trial (INS062 injection?INS068 injection?HR20014 injection)

      Not yet recruiting
      • Diabetes
      • INS062 injection、INS068 injection、HR20014 injection
      • (no location specified)
      May 24, 2023